No more than 15 authors can be listed.Please ensure the authors are listed in the right order.If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.
Malignant pleural effusion (MPE) is a frequent complication of advanced malignancy and is associated with significant morbidity, particularly dyspnea and hypoxemic respiratory failure. In a subset of patients, pleural fluid becomes complex, septated, and loculated, resulting in poor drainage despite appropriately positioned pleural catheters. While intrapleural fibrinolytic therapy is well established in the treatment of pleural infection, its role in MPE remains uncertain, and current guidelines offer limited guidance. We report a case demonstrating a marked clinical and radiological response of a complex MPE to a single low dose of intrapleural alteplase 5 mg administered without DNase.
A 60-year-old man with metastatic gastroesophageal junction adenocarcinoma presented with acute hypoxemic respiratory failure due to a massive, multiloculated right malignant pleural effusion. Despite placement of a pigtail catheter (10 Fr) followed by escalation to a 24 Fr chest tube, drainage remained minimal, and the patient required noninvasive ventilatory support. Bedside thoracic ultrasound confirmed persistent septated loculations. A single dose of intrapleural alteplase (5 mg diluted in 50 mL normal saline) was instilled via the chest tube, without DNase. Post-intrapleural alteplase instillation resulted in effective pleural drainage, with a total output of 1.7 L within 24 hours. Serial ultrasound of the chest demonstrated a resolution of the loculated MPE and improved lung re-expansion. The patient’s oxygenation and work of breathing improved rapidly, allowing de-escalation of ventilatory support. No bleeding or hemodynamic complications occurred.
This case illustrates that single-dose, low-dose intrapleural alteplase can be effective in restoring drainage and improving respiratory status in complex malignant pleural effusion, even without DNase. In MPE, fibrinous septation rather than DNA-rich purulence may be the dominant barrier to drainage, making fibrinolysis alone biologically plausible. For selected patients with advanced malignancy and high procedural or bleeding risk, a single dose of intrapleural alteplase may represent a pragmatic, safe, and effective palliative option.